A5062216376- Cardiac Arrhythmias and Treatments
- Cardiomyopathy and Myosin Studies
- Cardiac pacing and defibrillation studies
- Venous Thromboembolism Diagnosis and Management
- Atrial Fibrillation Management and Outcomes
- Cardiac tumors and thrombi
University Hospital Centre Zagreb
2021-2025
Implantable cardioverter defibrillators (ICDs) have significantly reduced the incidence of sudden cardiac death in patients with heart failure, particularly those ischemic disease. However, impact on overall mortality remains controversial, especially non-ischemic failure patients. The Danish Study to Assess Efficacy ICDs Patients Non-Ischemic Systolic Heart Failure (DANISH) trial and subsequent studies questioned efficacy this population, among older present study aimed evaluate survival...
Abstract Background Implantable cardioverter-defibrillators (ICDs) reduce sudden cardiac death (SCD) in heart failure (HF) patients, especially those with ischemic cardiomyopathy (ICM). However, the overall impact on mortality non-ischemic (NICM) is still debated. The DANISH trial raised questions about ICD efficacy NICM particularly older individuals, sparking concerns regarding patient selection and risk-benefit balance. This study evaluates survival outcomes, device activation, predictors...